Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill P Mesirov

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Science (New York, N.Y.)|January 23, 2010
Computer science. Accessible reproducible researchJill P Mesirov
Bioinformatics (Oxford, England)|March 11, 2026
Igv-reports: Embedding interactive genomic visualizations in HTML reports to aid variant reviewJames T Robinson, Helga Thorvaldsdottir, Jill P Mesirov
Briefings in Bioinformatics|April 21, 2012
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and explorationHelga Thorvaldsdóttir, James T Robinson, Jill P Mesirov
F1000Research|May 21, 2019
An accessible GenePattern notebook for the copy number variation analysis of Illumina Infinium DNA methylation arraysClarence K Mah, Jill P Mesirov, Lukas Chavez
Biorxiv : the Preprint Server for Biology|November 24, 2025
igv-reports: Embedding interactive genomic visualizations in HTML reports to aid variant reviewJames T Robinson, Helga Thorvaldsdottir, Jill P Mesirov
Statistical Methods in Medical Research|October 17, 2012
The limitations of simple gene set enrichment analysis assuming gene independencePablo Tamayo, George Steinhardt, Arthur Liberzon, et al.
Current Protocols in Bioinformatics|June 14, 2008
Using GenePattern for gene expression analysisHeidi Kuehn, Arthur Liberzon, Michael Reich, et al.
Bioinformatics (Oxford, England)|September 18, 2004
Improving genome annotations using phylogenetic profile anomaly detectionTarjei S Mikkelsen, James E Galagan, Jill P Mesirov
Cancer Discovery|October 4, 2024
Transforming Cancer Research through InformaticsJuli D Klemm, Dinah S Singer, Jill P Mesirov
Cell Reports|July 5, 2016
Kataegis Expression Signature in Breast Cancer Is Associated with Late Onset, Better Prognosis, and Higher HER2 LevelsMatteo D'Antonio, Pablo Tamayo, Jill P Mesirov, et al.
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Science (New York, N.Y.)|January 23, 2010
Computer science. Accessible reproducible researchJill P Mesirov
Bioinformatics (Oxford, England)|March 11, 2026
Igv-reports: Embedding interactive genomic visualizations in HTML reports to aid variant reviewJames T Robinson, Helga Thorvaldsdottir, Jill P Mesirov
Briefings in Bioinformatics|April 21, 2012
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and explorationHelga Thorvaldsdóttir, James T Robinson, Jill P Mesirov
F1000Research|May 21, 2019
An accessible GenePattern notebook for the copy number variation analysis of Illumina Infinium DNA methylation arraysClarence K Mah, Jill P Mesirov, Lukas Chavez
Biorxiv : the Preprint Server for Biology|November 24, 2025
igv-reports: Embedding interactive genomic visualizations in HTML reports to aid variant reviewJames T Robinson, Helga Thorvaldsdottir, Jill P Mesirov
Statistical Methods in Medical Research|October 17, 2012
The limitations of simple gene set enrichment analysis assuming gene independencePablo Tamayo, George Steinhardt, Arthur Liberzon, et al.
Current Protocols in Bioinformatics|June 14, 2008
Using GenePattern for gene expression analysisHeidi Kuehn, Arthur Liberzon, Michael Reich, et al.
Bioinformatics (Oxford, England)|September 18, 2004
Improving genome annotations using phylogenetic profile anomaly detectionTarjei S Mikkelsen, James E Galagan, Jill P Mesirov
Cancer Discovery|October 4, 2024
Transforming Cancer Research through InformaticsJuli D Klemm, Dinah S Singer, Jill P Mesirov
Cell Reports|July 5, 2016
Kataegis Expression Signature in Breast Cancer Is Associated with Late Onset, Better Prognosis, and Higher HER2 LevelsMatteo D'Antonio, Pablo Tamayo, Jill P Mesirov, et al.
Pageof 14